Utility of quantitative measurement of T2 using Restriction Spectrum Imaging for detection of clinically significant prostate cancer
Mariluz Rojo Domingo, Christopher C Conlin, Roshan A Karunamuni, Courtney Ollison, Madison T Baxter, Karoline Kallis, Deondre D Do, Yuze Song, Joshua M Kuperman, Ahmed S Shabaik, Michael E Hahn, Paul M Murphy, Rebecca Rakow-Penner, Anders M Dale, Tyler M Seibert
medRxiv 2024.03.29.24305033; doi: https://doi.org/10.1101/2024.03.29.24305033